The global market for Sexually Transmitted Diseases (STDs) Testing Devices was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Sexually Transmitted Diseases (STDs) Testing Devices was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Sexually Transmitted Diseases (STDs) Testing Devices was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Sexually Transmitted Diseases (STDs) Testing Devices was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Sexually Transmitted Diseases (STDs) Testing Devices include Roche Diagnostics, BioMerieux, Hologic, Inc., Becton Dickinson & Company, Cepheid, Inc., Danaher Corporation, Affymetrix, Inc., Alere, Inc. and Abbott Laboratories, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sexually Transmitted Diseases (STDs) Testing Devices, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Sexually Transmitted Diseases (STDs) Testing Devices by region & country, by Type, and by Application.
The Sexually Transmitted Diseases (STDs) Testing Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sexually Transmitted Diseases (STDs) Testing Devices.
麻豆原创 Segmentation
By Company
Roche Diagnostics
BioMerieux
Hologic, Inc.
Becton Dickinson & Company
Cepheid, Inc.
Danaher Corporation
Affymetrix, Inc.
Alere, Inc.
Abbott Laboratories
DiaSorin
Segment by Type:
Thermal Cyclers
Lateral Flow Readers
Flow Cytometers
Differential Light Scattering Machines
Others
Segment by Application
Laboratory Testing
Point of Care Testing
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Sexually Transmitted Diseases (STDs) Testing Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Sexually Transmitted Diseases (STDs) Testing Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Sexually Transmitted Diseases (STDs) Testing Devices in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Sexually Transmitted Diseases (STDs) Testing Devices Product Introduction
1.2 Global Sexually Transmitted Diseases (STDs) Testing Devices 麻豆原创 Size Forecast
1.2.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Value (2019-2030)
1.2.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Volume (2019-2030)
1.2.3 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Price (2019-2030)
1.3 Sexually Transmitted Diseases (STDs) Testing Devices 麻豆原创 Trends & Drivers
1.3.1 Sexually Transmitted Diseases (STDs) Testing Devices Industry Trends
1.3.2 Sexually Transmitted Diseases (STDs) Testing Devices 麻豆原创 Drivers & Opportunity
1.3.3 Sexually Transmitted Diseases (STDs) Testing Devices 麻豆原创 Challenges
1.3.4 Sexually Transmitted Diseases (STDs) Testing Devices 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Players Revenue Ranking (2023)
2.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Revenue by Company (2019-2024)
2.3 Global Sexually Transmitted Diseases (STDs) Testing Devices Players Sales Volume Ranking (2023)
2.4 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Volume by Company Players (2019-2024)
2.5 Global Sexually Transmitted Diseases (STDs) Testing Devices Average Price by Company (2019-2024)
2.6 Key Manufacturers Sexually Transmitted Diseases (STDs) Testing Devices Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Sexually Transmitted Diseases (STDs) Testing Devices Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Sexually Transmitted Diseases (STDs) Testing Devices
2.9 Sexually Transmitted Diseases (STDs) Testing Devices 麻豆原创 Competitive Analysis
2.9.1 Sexually Transmitted Diseases (STDs) Testing Devices 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Sexually Transmitted Diseases (STDs) Testing Devices Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Diseases (STDs) Testing Devices as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Thermal Cyclers
3.1.2 Lateral Flow Readers
3.1.3 Flow Cytometers
3.1.4 Differential Light Scattering Machines
3.1.5 Others
3.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Value by Type
3.2.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Value, by Type (2019-2030)
3.2.3 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Value, by Type (%) (2019-2030)
3.3 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Volume by Type
3.3.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Volume, by Type (2019-2030)
3.3.3 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Volume, by Type (%) (2019-2030)
3.4 Global Sexually Transmitted Diseases (STDs) Testing Devices Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Laboratory Testing
4.1.2 Point of Care Testing
4.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Value by Application
4.2.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Value, by Application (2019-2030)
4.2.3 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Value, by Application (%) (2019-2030)
4.3 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Volume by Application
4.3.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Volume, by Application (2019-2030)
4.3.3 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Volume, by Application (%) (2019-2030)
4.4 Global Sexually Transmitted Diseases (STDs) Testing Devices Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Value by Region
5.1.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Value by Region (2019-2024)
5.1.3 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Value by Region (2025-2030)
5.1.4 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Value by Region (%), (2019-2030)
5.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Volume by Region
5.2.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Volume by Region (2019-2024)
5.2.3 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Volume by Region (2025-2030)
5.2.4 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Volume by Region (%), (2019-2030)
5.3 Global Sexually Transmitted Diseases (STDs) Testing Devices Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Sexually Transmitted Diseases (STDs) Testing Devices Sales Value, 2019-2030
5.4.2 North America Sexually Transmitted Diseases (STDs) Testing Devices Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Sexually Transmitted Diseases (STDs) Testing Devices Sales Value, 2019-2030
5.5.2 Europe Sexually Transmitted Diseases (STDs) Testing Devices Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Sexually Transmitted Diseases (STDs) Testing Devices Sales Value, 2019-2030
5.6.2 Asia Pacific Sexually Transmitted Diseases (STDs) Testing Devices Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Sexually Transmitted Diseases (STDs) Testing Devices Sales Value, 2019-2030
5.7.2 South America Sexually Transmitted Diseases (STDs) Testing Devices Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Sexually Transmitted Diseases (STDs) Testing Devices Sales Value, 2019-2030
5.8.2 Middle East & Africa Sexually Transmitted Diseases (STDs) Testing Devices Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Sexually Transmitted Diseases (STDs) Testing Devices Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Sexually Transmitted Diseases (STDs) Testing Devices Sales Value
6.2.1 Key Countries/Regions Sexually Transmitted Diseases (STDs) Testing Devices Sales Value, 2019-2030
6.2.2 Key Countries/Regions Sexually Transmitted Diseases (STDs) Testing Devices Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Sexually Transmitted Diseases (STDs) Testing Devices Sales Value, 2019-2030
6.3.2 United States Sexually Transmitted Diseases (STDs) Testing Devices Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Sexually Transmitted Diseases (STDs) Testing Devices Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Sexually Transmitted Diseases (STDs) Testing Devices Sales Value, 2019-2030
6.4.2 Europe Sexually Transmitted Diseases (STDs) Testing Devices Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Sexually Transmitted Diseases (STDs) Testing Devices Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Sexually Transmitted Diseases (STDs) Testing Devices Sales Value, 2019-2030
6.5.2 China Sexually Transmitted Diseases (STDs) Testing Devices Sales Value by Type (%), 2023 VS 2030
6.5.3 China Sexually Transmitted Diseases (STDs) Testing Devices Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Sexually Transmitted Diseases (STDs) Testing Devices Sales Value, 2019-2030
6.6.2 Japan Sexually Transmitted Diseases (STDs) Testing Devices Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Sexually Transmitted Diseases (STDs) Testing Devices Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Sexually Transmitted Diseases (STDs) Testing Devices Sales Value, 2019-2030
6.7.2 South Korea Sexually Transmitted Diseases (STDs) Testing Devices Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Sexually Transmitted Diseases (STDs) Testing Devices Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Sexually Transmitted Diseases (STDs) Testing Devices Sales Value, 2019-2030
6.8.2 Southeast Asia Sexually Transmitted Diseases (STDs) Testing Devices Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Sexually Transmitted Diseases (STDs) Testing Devices Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Sexually Transmitted Diseases (STDs) Testing Devices Sales Value, 2019-2030
6.9.2 India Sexually Transmitted Diseases (STDs) Testing Devices Sales Value by Type (%), 2023 VS 2030
6.9.3 India Sexually Transmitted Diseases (STDs) Testing Devices Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Roche Diagnostics
7.1.1 Roche Diagnostics Company Information
7.1.2 Roche Diagnostics Introduction and Business Overview
7.1.3 Roche Diagnostics Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Roche Diagnostics Sexually Transmitted Diseases (STDs) Testing Devices Product Offerings
7.1.5 Roche Diagnostics Recent Development
7.2 BioMerieux
7.2.1 BioMerieux Company Information
7.2.2 BioMerieux Introduction and Business Overview
7.2.3 BioMerieux Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue and Gross Margin (2019-2024)
7.2.4 BioMerieux Sexually Transmitted Diseases (STDs) Testing Devices Product Offerings
7.2.5 BioMerieux Recent Development
7.3 Hologic, Inc.
7.3.1 Hologic, Inc. Company Information
7.3.2 Hologic, Inc. Introduction and Business Overview
7.3.3 Hologic, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Hologic, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Product Offerings
7.3.5 Hologic, Inc. Recent Development
7.4 Becton Dickinson & Company
7.4.1 Becton Dickinson & Company Company Information
7.4.2 Becton Dickinson & Company Introduction and Business Overview
7.4.3 Becton Dickinson & Company Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Becton Dickinson & Company Sexually Transmitted Diseases (STDs) Testing Devices Product Offerings
7.4.5 Becton Dickinson & Company Recent Development
7.5 Cepheid, Inc.
7.5.1 Cepheid, Inc. Company Information
7.5.2 Cepheid, Inc. Introduction and Business Overview
7.5.3 Cepheid, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Cepheid, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Product Offerings
7.5.5 Cepheid, Inc. Recent Development
7.6 Danaher Corporation
7.6.1 Danaher Corporation Company Information
7.6.2 Danaher Corporation Introduction and Business Overview
7.6.3 Danaher Corporation Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Danaher Corporation Sexually Transmitted Diseases (STDs) Testing Devices Product Offerings
7.6.5 Danaher Corporation Recent Development
7.7 Affymetrix, Inc.
7.7.1 Affymetrix, Inc. Company Information
7.7.2 Affymetrix, Inc. Introduction and Business Overview
7.7.3 Affymetrix, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Affymetrix, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Product Offerings
7.7.5 Affymetrix, Inc. Recent Development
7.8 Alere, Inc.
7.8.1 Alere, Inc. Company Information
7.8.2 Alere, Inc. Introduction and Business Overview
7.8.3 Alere, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Alere, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Product Offerings
7.8.5 Alere, Inc. Recent Development
7.9 Abbott Laboratories
7.9.1 Abbott Laboratories Company Information
7.9.2 Abbott Laboratories Introduction and Business Overview
7.9.3 Abbott Laboratories Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Abbott Laboratories Sexually Transmitted Diseases (STDs) Testing Devices Product Offerings
7.9.5 Abbott Laboratories Recent Development
7.10 DiaSorin
7.10.1 DiaSorin Company Information
7.10.2 DiaSorin Introduction and Business Overview
7.10.3 DiaSorin Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue and Gross Margin (2019-2024)
7.10.4 DiaSorin Sexually Transmitted Diseases (STDs) Testing Devices Product Offerings
7.10.5 DiaSorin Recent Development
8 Industry Chain Analysis
8.1 Sexually Transmitted Diseases (STDs) Testing Devices Industrial Chain
8.2 Sexually Transmitted Diseases (STDs) Testing Devices Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Sexually Transmitted Diseases (STDs) Testing Devices Sales Model
8.5.2 Sales Channel
8.5.3 Sexually Transmitted Diseases (STDs) Testing Devices Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Roche Diagnostics
BioMerieux
Hologic, Inc.
Becton Dickinson & Company
Cepheid, Inc.
Danaher Corporation
Affymetrix, Inc.
Alere, Inc.
Abbott Laboratories
DiaSorin
听
听
*If Applicable.
